Hi lazzaman, I’m in same boat somewhat with no experience in the pharmaceutical area but found some joy regarding patents and security processes in the research by Fiftyone Capital. PAR report is in the market insights area. Don’t know if it’s watertight.
Regards Tommy
FA bagger potential, page-48
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.050(15.4%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 37.5¢ | 34.0¢ | $980.3K | 2.746M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 34001 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 47595 | 6 |
View Market Depth
| Last trade - 11.39am 25/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
